Welcome! If you have a coupon code, click here to apply it. Apply

VRTX $0.00 ( +0.00%) Quote details

stock

Vertex Pharmaceuticals Inc

NASDAQ | VRTX

503.50

USD

+0.00 ( +0.00%)

AT CLOSE (AS OF Apr 29, 2025)

$128B

MARKET CAP

-

P/E Ratio

-2.07

EPS

$520

52 Week High

$378

52 Week Low

LIFE SCIENCES

Sector

VRTX Chart

1D
Area

Trade Smarter

Automate your trading workflow with powerful tools — built for serious traders.

Icon For Time-schedule

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Icon For Search

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Icon For Clipboard-list

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

VRTX Technicals

Tags:

VRTX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $9.5B
Total Revenue $11B
Cost Of Revenue $1.5B
Costof Goods And Services Sold $1.5B
Operating Income -$233M
Selling General And Administrative $1.5B
Research And Development $3.6B
Operating Expenses $9.7B
Investment Income Net -
Net Interest Income $568M
Interest Income $598M
Interest Expense $31M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $207M
Income Before Tax $249M
Income Tax Expense $784M
Interest And Debt Expense -
Net Income From Continuing Operations -$536M
Comprehensive Income Net Of Tax -
Ebit $279M
Ebitda $486M
Net Income -$536M

Revenue & Profitability

Earnings Performance

VRTX Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $23B
Total Current Assets $9.6B
Cash And Cash Equivalents At Carrying Value $4.6B
Cash And Short Term Investments $4.6B
Inventory $1.2B
Current Net Receivables $1.6B
Total Non Current Assets $13B
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $826M
Intangible Assets Excluding Goodwill $826M
Goodwill $1.1B
Investments -
Long Term Investments $5.1B
Short Term Investments $1.5B
Other Current Assets $666M
Other Non Current Assets -
Total Liabilities $6.1B
Total Current Liabilities $3.6B
Current Accounts Payable $413M
Deferred Revenue -
Current Debt -
Short Term Debt $92M
Total Non Current Liabilities $2.6B
Capital Lease Obligations $1.7B
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $1.7B
Other Current Liabilities $2.9B
Other Non Current Liabilities $203M
Total Shareholder Equity $16B
Treasury Stock -
Retained Earnings $9.6B
Common Stock $2.6M
Common Stock Shares Outstanding $258M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$493M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $207M
Capital Expenditures $298M
Change In Receivables -
Change In Inventory -$517M
Profit Loss -
Cashflow From Investment -
Cashflow From Financing -$1.5B
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$1.6B
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$536M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $9.5B
Total Revenue $11B
Cost Of Revenue $1.5B
Costof Goods And Services Sold $1.5B
Operating Income -$233M
Selling General And Administrative $1.5B
Research And Development $3.6B
Operating Expenses $9.7B
Investment Income Net -
Net Interest Income $568M
Interest Income $598M
Interest Expense $31M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $207M
Income Before Tax $249M
Income Tax Expense $784M
Interest And Debt Expense -
Net Income From Continuing Operations -$536M
Comprehensive Income Net Of Tax -
Ebit $279M
Ebitda $486M
Net Income -$536M

VRTX News

VRTX Profile

Vertex Pharmaceuticals Inc Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.

DMN
97.37%
$0.0075
LGMK
26.36%
$0.0163
WW
77.03%
$0.732
PTPI
-77.55%
$0.013
GNLN
5.83%
$0.0127
AGMH
-23.58%
$0.1024
BON
11.54%
$0.0725
PLUG
-5.96%
$0.9592
DGLY
19.68%
$0.0377
SOFI
0.53%
$13.27
NVDA
0.27%
$109.02
HIMS
23.03%
$35.04
F
1.30%
$10.15
AMCR
-3.12%
$9.33
CYCC
59.06%
$0.3038
TSLA
2.15%
$292.03
SNAP
2.94%
$9.09
PFE
3.21%
$23.79
PLTR
1.25%
$116.08
OMH
49.26%
$3.03
LCID
1.19%
$2.56
INTC
-0.83%
$20.34
DNN
-2.74%
$1.42
AAL
0.51%
$9.9
NVNI
37.51%
$0.213
LYT
-16.78%
$0.0982
RIG
-4.76%
$2.2
ABEV
2.01%
$2.54
NIO
-1.62%
$4.24
WLDS
50.00%
$1.8
RIOT
-2.75%
$7.42
JBLU
2.70%
$4.18
SMCI
-3.41%
$36
AMZN
-0.17%
$187.39
AGNC
0.55%
$9.07
MARA
1.50%
$14.22
AAPL
0.51%
$211.21
ITUB
1.61%
$6.31
BBD
1.67%
$2.43
BAC
0.53%
$39.99
GRAB
0.63%
$4.79
BTE
-3.61%
$1.6
QBTS
-5.02%
$7
CCL
-0.80%
$18.71
WULF
-3.31%
$2.92
ME
-21.26%
$0.6063
CUTR
-10.19%
$0.0969
ERIC
0.73%
$8.3
HOOD
0.90%
$49.37
TLRY
2.71%
$0.4898
BTG
0.32%
$3.1
GOOGL
-0.28%
$160.16
LUV
2.29%
$27.26
ONCO
-4.88%
$0.0761
APLD
-4.88%
$4.48
WBD
0.80%
$8.77
AZUL
-4.55%
$0.84
T
0.15%
$27.3
VALE
0.00%
$9.6
WFC
2.41%
$71.1
AVTR
1.60%
$12.69
GM
-0.64%
$46.94
EJH
-15.20%
$0.7802
ACHR
5.39%
$8.99
LFMD
41.31%
$8.62
LYG
0.51%
$3.98
OMEX
9.85%
$1.45
AMD
-0.34%
$96.06
PBR
0.09%
$11.52
PONY
-6.49%
$9.65
AEG
-0.15%
$6.52
BMY
1.57%
$49.22
NGD
-0.59%
$3.35
PYPL
2.14%
$66.32
RGTI
-3.90%
$8.86
FNA
0.00%
$13.09
BERY
-2.93%
$67.58
MRK
1.83%
$84.71
CLSK
-1.52%
$8.44
STLA
2.46%
$9.59
RIVN
0.83%
$13.3
IQ
-0.53%
$1.88
HTZ
-13.63%
$7.35
NCLH
-0.34%
$17.38
IXHL
-75.10%
$0.1519
FUBO
-0.96%
$3.1
AG
0.16%
$6.25
MU
-2.14%
$76.88
BP
-3.64%
$28.07
SBUX
1.13%
$84.85
CDE
-2.98%
$5.53
KO
0.78%
$72.35
OCEA
15.15%
$0.0076
NOK
1.22%
$4.97
GOOG
-0.22%
$162.06
VRN
-1.62%
$6.09
IBIO
0.00%
$1.05
HL
-1.19%
$5.8
MSFT
0.74%
$394.04
ABEO
-0.93%
$5.3
DMN
97.37%
$0.0075
LGMK
26.36%
$0.0163
WW
77.03%
$0.732
PTPI
-77.55%
$0.013
GNLN
5.83%
$0.0127
AGMH
-23.58%
$0.1024
BON
11.54%
$0.0725
PLUG
-5.96%
$0.9592
DGLY
19.68%
$0.0377
SOFI
0.53%
$13.27
NVDA
0.27%
$109.02
HIMS
23.03%
$35.04
F
1.30%
$10.15
AMCR
-3.12%
$9.33
CYCC
59.06%
$0.3038
TSLA
2.15%
$292.03
SNAP
2.94%
$9.09
PFE
3.21%
$23.79
PLTR
1.25%
$116.08
OMH
49.26%
$3.03
LCID
1.19%
$2.56
INTC
-0.83%
$20.34
DNN
-2.74%
$1.42
AAL
0.51%
$9.9
NVNI
37.51%
$0.213
LYT
-16.78%
$0.0982
RIG
-4.76%
$2.2
ABEV
2.01%
$2.54
NIO
-1.62%
$4.24
WLDS
50.00%
$1.8
RIOT
-2.75%
$7.42
JBLU
2.70%
$4.18
SMCI
-3.41%
$36
AMZN
-0.17%
$187.39
AGNC
0.55%
$9.07
MARA
1.50%
$14.22
AAPL
0.51%
$211.21
ITUB
1.61%
$6.31
BBD
1.67%
$2.43
BAC
0.53%
$39.99
GRAB
0.63%
$4.79
BTE
-3.61%
$1.6
QBTS
-5.02%
$7
CCL
-0.80%
$18.71
WULF
-3.31%
$2.92
ME
-21.26%
$0.6063
CUTR
-10.19%
$0.0969
ERIC
0.73%
$8.3
HOOD
0.90%
$49.37
TLRY
2.71%
$0.4898
BTG
0.32%
$3.1
GOOGL
-0.28%
$160.16
LUV
2.29%
$27.26
ONCO
-4.88%
$0.0761
APLD
-4.88%
$4.48
WBD
0.80%
$8.77
AZUL
-4.55%
$0.84
T
0.15%
$27.3
VALE
0.00%
$9.6
WFC
2.41%
$71.1
AVTR
1.60%
$12.69
GM
-0.64%
$46.94
EJH
-15.20%
$0.7802
ACHR
5.39%
$8.99
LFMD
41.31%
$8.62
LYG
0.51%
$3.98
OMEX
9.85%
$1.45
AMD
-0.34%
$96.06
PBR
0.09%
$11.52
PONY
-6.49%
$9.65
AEG
-0.15%
$6.52
BMY
1.57%
$49.22
NGD
-0.59%
$3.35
PYPL
2.14%
$66.32
RGTI
-3.90%
$8.86
FNA
0.00%
$13.09
BERY
-2.93%
$67.58
MRK
1.83%
$84.71
CLSK
-1.52%
$8.44
STLA
2.46%
$9.59
RIVN
0.83%
$13.3
IQ
-0.53%
$1.88
HTZ
-13.63%
$7.35
NCLH
-0.34%
$17.38
IXHL
-75.10%
$0.1519
FUBO
-0.96%
$3.1
AG
0.16%
$6.25
MU
-2.14%
$76.88
BP
-3.64%
$28.07
SBUX
1.13%
$84.85
CDE
-2.98%
$5.53
KO
0.78%
$72.35
OCEA
15.15%
$0.0076
NOK
1.22%
$4.97
GOOG
-0.22%
$162.06
VRN
-1.62%
$6.09
IBIO
0.00%
$1.05
HL
-1.19%
$5.8
MSFT
0.74%
$394.04
ABEO
-0.93%
$5.3
Discover more tools and features to empower your trading
Explore Features

Quotes and other market data may be delayed by 15 minutes or more. Financial data is provided by financial exchanges and other content providers and may be delayed as specified by financial exchanges or other data providers. AfterPullback does not verify any data and disclaims any obligation to do so. The information contained on this website is not intended as, and shall not be understood as, financial advice. The website does not operated by attorney, accountant or financial advisor and the information contained on this website is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation. Nothing available on or through this website should be understood as a recommendation that you should not consult with a financial professional to address your particular information.